About: PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.35 (-2.17%)
PMVP NASDAQ Pmv Pharmaceuticals Inc
Pmv Pharmaceuticals Inc share price
Atividade de preço de PMVP
Último preço
$ 1,320
Variação (24h)
-0,06 USD (4,65%)
Volume
238.11K
Volume (média 4 sem.)
-
Abertura
$ 1,39
Variação do dia
$ 1,32 - $ 1,39
Fechamento anterior
$ 1,38
Último negócio
29 Oct, 8:05 pm GMT+0
Atrasado
29 Oct, 8:05 pm GMT+0
PMVP price performance
Atrasado
29 Oct, 8:05 pm GMT+0
quote.marketSignals